Form 4: Zimmer Biomet Executive Sang Yi Reports Stock Transactions

Sang Yi, Group President of Asia Pacific at Zimmer Biomet, reports the acquisition and vesting of restricted stock units and shares acquired through employee stock purchase and dividend reinvestment.

Summary

• On February 18, 2025, Sang Yi, Group President of Asia Pacific at Zimmer Biomet Holdings, Inc., reported transactions involving the company's stock.
• Yi acquired 11,138 shares of common stock through the vesting of restricted stock units (RSUs).
• These RSUs were granted on February 18, 2022, and their vesting was contingent upon meeting certain performance conditions over the period of 2022-2024.
• The performance conditions were met, resulting in the vesting of the RSUs on February 18, 2025.
• Yi also acquired 216 shares through the Employee Stock Purchase Plan and dividend reinvestment through February 18, 2025.
• Following these transactions, Yi directly owns 16,676 shares of Zimmer Biomet common stock and 11,138 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating the vesting of RSUs based on pre-defined performance metrics. There's no indication of unusual or concerning activity.

Positives

• The vesting of RSUs indicates that performance targets were met, which could be viewed positively.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and recent activities related to the company's stock.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation.

Key Dates

Keywords

Zimmer Biomet, Sang Yi, RSU, Stock, Form 4, Beneficial Ownership, Transactions